United States · FDA National Drug Code directory
Polyethylene Glycol
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68001-505_cc6e2865-14e2-1ac7-e053-2a95a90acbc0
- Product NDC
- 68001-505
- Form
- POWDER, FOR SUSPENSION
- Composition / generic term
- Polyethylene Glycol
- Labeler
- BluePoint Laboratories
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210618
- Source listing expiry
- 20261231
Source-listed ingredients
- POLYETHYLENE GLYCOL 3350 — 17 g/17g
These values do not establish equivalence or a dose recommendation.
Packages
- 238 g in 1 BOTTLE (68001-505-55) · 68001-505-55
- 510 g in 1 BOTTLE (68001-505-69) · 68001-505-69
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →